<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">The primary endpoint was the occurrence of BOS 6 months after inclusion. Secondary endpoints were the occurrence of AR and the quantitative change of forced expiratory volume in 1â€‰s (FEV-1) at 6 months after inclusion, as well as death during the whole study period.</p>
